CLINICAL_TRIALS
research
· 2026-01-20
Clinical Trial Update: Effectiveness of Aquamin® in Mitigating Halitosis [Phase 2]
Summary
This Phase 2 clinical trial evaluates the effectiveness of Aquamin in mitigating halitosis and is currently active but not recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Michigan | Conditions: Healthy, Halitosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING